ProfileGDS4718 / 218896_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 83% 86% 85% 85% 77% 76% 83% 84% 83% 85% 88% 83% 76% 83% 85% 81% 80% 81% 76% 85% 84% 85% 87% 86% 79% 87% 87% 86% 73% 77% 78% 85% 87% 77% 76% 77% 86% 85% 85% 83% 74% 81% 78% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.5137985
GSM549102patient 115, normal, homogenized [OPG study]8.2076383
GSM549104patient 119, normal, homogenized [OPG study]8.638886
GSM549108patient 138, normal, homogenized [OPG study]8.4213885
GSM549119patient 077, normal, homogenized [OPG study]8.4631785
GSM549133patient 032, cancer, homogenized [OPG study]7.651577
GSM549139patient 042, cancer, homogenized [OPG study]7.4877476
GSM549099patient 107, normal, homogenized [OPG study]8.1041683
GSM549109patient 139, normal, homogenized [OPG study]8.3010784
GSM549110patient 046, normal, homogenized [OPG study]8.1509483
GSM549114patient 063, normal, homogenized [OPG study]8.5211785
GSM549122patient 082, normal, homogenized [OPG study]8.885888
GSM549134patient 033, cancer, homogenized [OPG study]8.2177883
GSM549136patient 036, cancer, homogenized [OPG study]7.5609376
GSM549140patient 044, cancer, homogenized [OPG study]8.2708683
GSM549111patient 047, normal, homogenized [OPG study]8.5599885
GSM549113patient 057, normal, homogenized [OPG study]8.1228681
GSM549132patient 031, cancer, homogenized [OPG study]7.8996180
GSM549137patient 038, cancer, homogenized [OPG study]7.9781981
GSM549142patient 047, cancer, homogenized [OPG study]7.2531276
GSM549100patient 110, normal, homogenized [OPG study]8.3590985
GSM549107patient 135, normal, homogenized [OPG study]8.3950284
GSM549115patient 068, normal, homogenized [OPG study]8.5725685
GSM549116patient 072, normal, homogenized [OPG study]8.8463487
GSM549120patient 078, normal, homogenized [OPG study]8.6031986
GSM549131patient 030, cancer, homogenized [OPG study]7.8446279
GSM549118patient 074, normal, homogenized [OPG study]8.8276887
GSM549129patient 027, cancer, homogenized [OPG study]8.6597787
GSM549123patient 088, normal, homogenized [OPG study]8.6170586
GSM549124patient 006, cancer, homogenized [OPG study]7.1082273
GSM549126patient 015, cancer, homogenized [OPG study]7.5008277
GSM549128patient 025, cancer, homogenized [OPG study]7.7409978
GSM549103patient 117, normal, homogenized [OPG study]8.2757885
GSM549117patient 073, normal, homogenized [OPG study]8.918587
GSM549138patient 041, cancer, homogenized [OPG study]7.556777
GSM549141patient 045, cancer, homogenized [OPG study]7.582576
GSM549130patient 028, cancer, homogenized [OPG study]7.4808377
GSM549101patient 111, normal, homogenized [OPG study]8.5205486
GSM549105patient 128, normal, homogenized [OPG study]8.4715785
GSM549106patient 134, normal, homogenized [OPG study]8.6056985
GSM549112patient 048, normal, homogenized [OPG study]8.2785983
GSM549125patient 011, cancer, homogenized [OPG study]7.1779774
GSM549127patient 024, cancer, homogenized [OPG study]7.9827481
GSM549135patient 035, cancer, homogenized [OPG study]7.7658478